Bank of Montreal
TRML

Bank of Montreal’s Tourmaline Bio TRML Stock Holding History

Bank of Montreal’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,250
Closed -$34.9K – 4298
2023
Q3 		$34.9K Sell
1,250
-20
-2% -$586 ﹤0.01% 3491
2023
Q2 		$40.5K Sell
1,270
-326
-20% -$8.32K ﹤0.01% 3632
2023
Q1 		$30.6K Buy
+1,596
New +$26.3K ﹤0.01% 3452
2022
Q4 		– Sell
-33,406
Closed -$1.19K – 4286
2022
Q3 		$1.19K Buy
33,406
+31,162
+1,389% +$1.14M ﹤0.01% 2074
2022
Q2 		$203 Buy
+2,244
New +$177K ﹤0.01% 3269

Other funds holding TRML

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Bank of Montreal's TRML Position: Q4 2023 in Review

Bank of Montreal sold out of Tourmaline Bio (TRML) in Q4 2023, closing a stake of 1,250 shares — an estimated $34.9K sold.

Bank of Montreal first reported a position in TRML in Q2 2022 and held it in 5 quarters. The position peaked at $40.5K in Q2 2023. 54 funds tracked by Wall St. Rank hold TRML as of Q4 2023.

  • Bank of Montreal reported no remaining Tourmaline Bio position as of Q4 2023 after selling out during the quarter.
  • Bank of Montreal sold 1,250 Tourmaline Bio shares in Q4 2023, an estimated $34.9K.
  • Bank of Montreal first reported a position in Tourmaline Bio in Q2 2022 and held it in 5 quarters.
  • Bank of Montreal's Tourmaline Bio position peaked at $40.5K in Q2 2023.
  • 54 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2023.

Based on Bank of Montreal's 13F filing for Q4 2023, filed 8 Feb 2024.